102 related articles for article (PubMed ID: 24694612)
21. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
22. Ras/MAPK pathway confers basement membrane dependence upon endoderm differentiation of embryonic carcinoma cells.
Smedberg JL; Smith ER; Capo-Chichi CD; Frolov A; Yang DH; Godwin AK; Xu XX
J Biol Chem; 2002 Oct; 277(43):40911-8. PubMed ID: 12145292
[TBL] [Abstract][Full Text] [Related]
23. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
24. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
25. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.
Kurpios NA; MacNeil L; Shepherd TG; Gludish DW; Giacomelli AO; Hassell JA
Dev Biol; 2009 Jan; 325(1):106-21. PubMed ID: 18977342
[TBL] [Abstract][Full Text] [Related]
26. SC1 inhibits the differentiation of F9 embryonic carcinoma cells induced by retinoic acid.
Liu Y; Ren X; Ke J; Zhang Y; Wei Q; Shi Z; Ai Z; Guo Z
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):793-799. PubMed ID: 29945210
[TBL] [Abstract][Full Text] [Related]
27. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
28. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
[TBL] [Abstract][Full Text] [Related]
29. Involvement of polyomavirus enhancer activator 3 in the regulation of expression of gamma-glutamyl transpeptidase messenger ribonucleic acid-IV in the rat epididymis.
Lan ZJ; Lye RJ; Holic N; Labus JC; Hinton BT
Biol Reprod; 1999 Mar; 60(3):664-73. PubMed ID: 10026114
[TBL] [Abstract][Full Text] [Related]
30. Preferential differentiation of P19 mouse embryonal carcinoma cells into smooth muscle cells. Use of retinoic acid and antisense against the central nervous system-specific POU transcription factor Brn-2.
Suzuki T; Kim HS; Kurabayashi M; Hamada H; Fujii H; Aikawa M; Watanabe M; Watanabe N; Sakomura Y; Yazaki Y; Nagai R
Circ Res; 1996 Mar; 78(3):395-404. PubMed ID: 8593698
[TBL] [Abstract][Full Text] [Related]
31. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
32. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
33. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.
Baert JL; Monté D; Musgrove EA; Albagli O; Sutherland RL; de Launoit Y
Int J Cancer; 1997 Mar; 70(5):590-7. PubMed ID: 9052761
[TBL] [Abstract][Full Text] [Related]
34. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
35. Determination of the consensus DNA-binding sequence and a transcriptional activation domain for ESE-2.
Choi YS; Sinha S
Biochem J; 2006 Sep; 398(3):497-507. PubMed ID: 16704374
[TBL] [Abstract][Full Text] [Related]
36. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
[TBL] [Abstract][Full Text] [Related]
37. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa.
Dissanayake K; Toth R; Blakey J; Olsson O; Campbell DG; Prescott AR; MacKintosh C
Biochem J; 2011 Feb; 433(3):515-25. PubMed ID: 21087211
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of the ets-related human transcription factor ER81.
Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
[TBL] [Abstract][Full Text] [Related]
39. The Ets family of transcription factors.
Wasylyk B; Hahn SL; Giovane A
Eur J Biochem; 1993 Jan; 211(1-2):7-18. PubMed ID: 8425553
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
